Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

640 public trials 137 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Completed

Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

NCT01482156

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +20 more
Locations
  • Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States
  • Washington University School of Medicine Washington University (16) St Louis, Missouri, United States
  • Medical University of South Carolina SC Charleston, South Carolina, United States
  • Novartis Investigative Site Wilrijk, Belgium
View Trial Details
Completed

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

NCT01576666

Conditions
Advanced Pancreatic Adenocarcinoma, Advanced Solid Tumors, Astrocytoma, +35 more
Locations
  • Cedars Sinai Medical Center SC Los Angeles, California, United States
  • University of California San Francisco UCSF (SC) San Francisco, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Moffitt 4 Tampa, Florida, United States
  • Dana Farber Cancer Institute Dana SC Boston, Massachusetts, United States
View all 23 locations
View Trial Details
Completed

A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer

NCT00788931

Conditions
Breast Diseases, Breast Neoplasms, HER-2 Positive Breast Cancer, +5 more
Locations
  • Novartis Investigative Site Mobile, Alabama, United States
  • Novartis Investigative Site Woodville, South Australia, Australia
  • Novartis Investigative Site Brussels, Belgium
  • Novartis Investigative Site Liège, Belgium
View Trial Details
Completed

Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer

NCT00958971

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Comprehensive Blood and Cancer Center Dept CBCC (3) Bakersfield, California, United States
  • Tower Cancer Research Beverly Hills, California, United States
  • UCLA/ University of California Los Angeles Div. of Hematology/Oncology Los Angeles, California, United States
  • Cancer Care Associates Medical Group Dept. of CCA Redondo Beach, California, United States
View all 38 locations
View Trial Details
Completed

Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer

NCT01338831

Conditions
Breast Diseases, Breast Neoplasms, Castration-resistant Prostate Cancer, +19 more
Locations
  • Massachusetts General Hospital Mass Gen 3 Boston, Massachusetts, United States
  • Cancer Institute of New Jersey SC New Brunswick, New Jersey, United States
  • Thomas Jefferson University, Dept. of Phsyciatry & Neurology Thomas Jefferson Philadelphia, Pennsylvania, United States
  • University of Utah / Huntsman Cancer Institute Huntsman 3 Salt Lake City, Utah, United States
View Trial Details
Completed

Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects

NCT01516307

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • The University of Alabama at Birmingham (UAB) Birmingham, Alabama, United States
  • St. Jude Heritage Healthcare, Virginia K. Crosson Cancer Center Fullerton, California, United States
  • University of California, San Diego (UCSD) La Jolla, California, United States
  • University of California, Irvine (UCI) Orange, California, United States
View all 43 locations
View Trial Details
Completed

A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer

NCT01973309

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Cedars-Sinai Medical Center/ Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Texas Oncology-Baylor Charles A. Sammons Cancer Center Dallas, Texas, United States
  • Texas Oncology-Tyler Tyler, Texas, United States
View Trial Details

Related conditions